Survival in Liver Transplant Recipients with Hepatitis B- or Hepatitis C-Associated Hepatocellular Carcinoma: The Chinese Experience from 1999 to 2010

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Hu, Zhenhua ^a   Zhou, Jie ^a   Wang, Haibo ^b   Zhang, Min ^a   Li, Shaogang ^b   Huang, Yuzhou ^b   Wu, Jian ^a   Li, Zhiwei ^a   Zhou, Lin ^a   Zheng, Shusen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b China Liver Transplant Registry   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGE; AGED; ARTICLE; BILIARY TRACT DISEASE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; REGISTER; SEX DIFFERENCE; SEX RATIO; SURVIVAL RATE; TUMOR VOLUME; VASCULAR DISEASE;

EID: 84876164434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061620     Document Type: Article

References (46)

1. Parkin DM, (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030-3044.
2. Castello G, Scala S, Palmieri G, Curley SA, Izzo F, (2010) HCV-related hepatocellular carcinoma: From chronic inflammation to cancer. Clin Immunol 134: 237-250.
3. Lai CL, Ratziu V, Yuen MF, Poynard T, (2003) Viral hepatitis B. Lancet. 362: 2089-2094.
4. Liu J, Fan D, (2007) Hepatitis B in China. Lancet 369: 1582-1583.
5. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, et al. (2004) Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38: S158-168.
6. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
7. Chisari FV, (2005) Unscrambling hepatitis C virus-host interactions. Nature 436: 930-932.
8. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, et al. (2011) A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 31Suppl 2: 61-80.
9. Gane EJ, (2008) The natural history of recurrent hepatitis C and what influences this. Liver Transpl 14Suppl 2: S36-44.
10. Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, et al. (2009) Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transpl 15: 1525-1534.
11. Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, et al. (1999) European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 117: 619-625.
12. Berenguer M, Prieto M, Rayon JM, Mora J, Pastor M, et al. (2000) Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 32: 852-858.
13. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, et al. (2000) HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32: 673-684.
14. Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, et al. (1998) Characteristics of hepatocellular carcinoma in Italy. J Hepatol 29: 944-952.
15. Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH, (1994) Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 19: 222-226.
16. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, et al. (1995) Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 22: 1027-1033.
17. Miyagawa S, Kawasaki S, Makuuchi M, (1996) Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology. 24: 307-310.
18. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR, (2002) The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122: 889-896.
19. Yataco M, Bonatti H, Machicao V, Mendez J, Stauffer J, et al. (2010) Long term survival and complications after liver transplantation in patients with chronic hepatitis B. Ann Transplant. 15: 27-34.
20. Zheng SS, Xu X, Wu J, Chen J, Wang WL, et al. (2008) Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 85: 1726-1732.
21. Wong PY, McPeake JR, Portmann B, Tan KC, Naoumov NV, et al. (1995) Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma. Am J Gastroenterol 90: 29-34.
22. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699.
23. Neuveut C, Wei Y, Buendia MA, (2010) Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 52: 594-604.
24. Farazi PA, DePinho RA, (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687.
25. Cholongitas E, Goulis J, Akriviadis E, Papatheodoridis GV, (2011) Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review. Liver Transpl 17: 1176-1190.
26. Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Reed A, Hemming A, et al. (2002) Combination of interferon alfa-2 b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl. 8: 1000-1006.
27. Belli LS, Volpes R, Graziadei I, Fagiuoli S, Starkel P, et al. (2012) Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study. Dig Liver Dis.
28. Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, et al. (2007) Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl 13: 807-813.
29. Rehermann B, Nascimbeni M, (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229.
30. Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, et al. (1995) Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci U S A 92: 2755-2759.
31. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, et al. (2002) Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 62: 3939-3944.
32. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, et al. (2001) Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61: 2129-2137.
33. Kim W, Lim SO, Kim JS, Ryu YH, Byeon JY, et al. (2003) Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. Clin Cancer Res 9: 5493-5500.
34. Waki K, Sugawara Y, Tamura S, Mieno MN, Yamashiki N, et al. (2011) Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data. Transplantation 92: 809-814.
35. Burra P, Senzolo M, Masier A, Prestele H, Jones R, et al. (2009) Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Dig Liver Dis 41: 350-356.
36. Johnson RJ, Couser WG, (1990) Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37: 663-676.
37. Lee JP, Heo NJ, Joo KW, Yi NJ, Suh KS, et al. (2010) Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function. Nephrol Dial Transplant 25: 2772-2785.
38. Seehofer D, Berg T, (2005) Prevention of hepatitis B recurrence after liver transplantation. Transplantation 80: S120-124.
39. Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, et al. (1999) Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 17: 324-331.
40. Han SH, Reddy KR, Keeffe EB, Soldevila-Pico C, Gish R, et al. (2011) Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study. Clin Transplant 25: E152-162.
41. Berenguer M, (2002) Natural history of recurrent hepatitis C. Liver Transpl. 8: S14-18.
42. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, et al. (2007) Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. Transplant Proc. 39: 3276-3280.
43. Chun J, Kim W, Kim BG, Lee KL, Suh KS, et al. (2010) High viremia, prolonged Lamivudine therapy and recurrent hepatocellular carcinoma predict posttransplant hepatitis B recurrence. Am J Transplant 10: 1649-1659.
44. Faria LC, Gigou M, Roque-Afonso AM, Sebagh M, Roche B, et al. (2008) Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology 134: 1890-1899; quiz 2155.
45. Yi NJ, Suh KS, Cho JY, Kwon CH, Lee KW, et al. (2007) Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl 13: 451-458.
46. Li MR, Chen GH, Cai CJ, Wang GY, Zhao H, (2011) High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence. Digestion 84: 134-141.